

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of histone deacetylation (GO:0031065) | 5.24600886 |
| 2 | daunorubicin metabolic process (GO:0044597) | 5.00620478 |
| 3 | polyketide metabolic process (GO:0030638) | 5.00620478 |
| 4 | doxorubicin metabolic process (GO:0044598) | 5.00620478 |
| 5 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.99812904 |
| 6 | maintenance of protein location in nucleus (GO:0051457) | 4.56060395 |
| 7 | histone H4-K12 acetylation (GO:0043983) | 4.48235761 |
| 8 | positive regulation of protein deacetylation (GO:0090312) | 4.46693709 |
| 9 | histone H4-K8 acetylation (GO:0043982) | 4.40687286 |
| 10 | histone H4-K5 acetylation (GO:0043981) | 4.40687286 |
| 11 | pre-miRNA processing (GO:0031054) | 4.06233723 |
| 12 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.95776745 |
| 13 | maternal placenta development (GO:0001893) | 3.93359390 |
| 14 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.88639738 |
| 15 | muscle organ morphogenesis (GO:0048644) | 3.84516259 |
| 16 | mannose metabolic process (GO:0006013) | 3.79707483 |
| 17 | regulation of response to osmotic stress (GO:0047484) | 3.79022409 |
| 18 | histone H4-K16 acetylation (GO:0043984) | 3.74769748 |
| 19 | somite rostral/caudal axis specification (GO:0032525) | 3.73539120 |
| 20 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.69048935 |
| 21 | histone H3-K36 demethylation (GO:0070544) | 3.66704248 |
| 22 | negative regulation of epidermis development (GO:0045683) | 3.66396351 |
| 23 | proline transport (GO:0015824) | 3.61334626 |
| 24 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.61032483 |
| 25 | hormone catabolic process (GO:0042447) | 3.60951154 |
| 26 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 3.59352886 |
| 27 | apoptotic process involved in morphogenesis (GO:0060561) | 3.58927701 |
| 28 | ribosomal small subunit biogenesis (GO:0042274) | 3.57781161 |
| 29 | NLS-bearing protein import into nucleus (GO:0006607) | 3.55576150 |
| 30 | protein localization to kinetochore (GO:0034501) | 3.54944317 |
| 31 | adherens junction assembly (GO:0034333) | 3.53563276 |
| 32 | cell-substrate adherens junction assembly (GO:0007045) | 3.51885691 |
| 33 | focal adhesion assembly (GO:0048041) | 3.51885691 |
| 34 | negative regulation of cell size (GO:0045792) | 3.49148172 |
| 35 | interferon-gamma production (GO:0032609) | 3.48312476 |
| 36 | negative regulation of telomerase activity (GO:0051974) | 3.47337920 |
| 37 | regulation of chromatin binding (GO:0035561) | 3.45380528 |
| 38 | RNA stabilization (GO:0043489) | 3.44578708 |
| 39 | mRNA stabilization (GO:0048255) | 3.44578708 |
| 40 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.38084918 |
| 41 | hypotonic response (GO:0006971) | 3.37249876 |
| 42 | regulation of histone H3-K27 methylation (GO:0061085) | 3.33568970 |
| 43 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.33400658 |
| 44 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.32455566 |
| 45 | cytidine metabolic process (GO:0046087) | 3.30669088 |
| 46 | cytidine catabolic process (GO:0006216) | 3.30669088 |
| 47 | cytidine deamination (GO:0009972) | 3.30669088 |
| 48 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.26829104 |
| 49 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.25199701 |
| 50 | Golgi transport vesicle coating (GO:0048200) | 3.21543313 |
| 51 | COPI coating of Golgi vesicle (GO:0048205) | 3.21543313 |
| 52 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.19123026 |
| 53 | regulation of hippo signaling (GO:0035330) | 3.17740215 |
| 54 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 3.17675048 |
| 55 | maintenance of protein localization in organelle (GO:0072595) | 3.16860068 |
| 56 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.15038136 |
| 57 | retinoic acid receptor signaling pathway (GO:0048384) | 3.14786005 |
| 58 | establishment of endothelial barrier (GO:0061028) | 3.14218773 |
| 59 | trophectodermal cell differentiation (GO:0001829) | 3.11078037 |
| 60 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.11049401 |
| 61 | negative regulation of viral release from host cell (GO:1902187) | 3.10139948 |
| 62 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.09252059 |
| 63 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.08016261 |
| 64 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.05417876 |
| 65 | protein complex localization (GO:0031503) | 3.00898121 |
| 66 | natural killer cell differentiation (GO:0001779) | 2.99721209 |
| 67 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.97029114 |
| 68 | nuclear pore complex assembly (GO:0051292) | 2.95183925 |
| 69 | synaptic vesicle maturation (GO:0016188) | 2.94223267 |
| 70 | rRNA transcription (GO:0009303) | 2.92000248 |
| 71 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.91608226 |
| 72 | regulation of RNA export from nucleus (GO:0046831) | 2.91068027 |
| 73 | mitotic chromosome condensation (GO:0007076) | 2.90203205 |
| 74 | apoptotic cell clearance (GO:0043277) | 2.88480217 |
| 75 | positive regulation of macrophage cytokine production (GO:0060907) | 2.88367787 |
| 76 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.86732974 |
| 77 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 2.85728874 |
| 78 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.83377013 |
| 79 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.83132565 |
| 80 | response to dietary excess (GO:0002021) | 2.82884128 |
| 81 | adaptation of signaling pathway (GO:0023058) | 2.81244412 |
| 82 | positive regulation of Rap GTPase activity (GO:0032854) | 2.81080225 |
| 83 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.81072842 |
| 84 | barbed-end actin filament capping (GO:0051016) | 2.79928781 |
| 85 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.79310913 |
| 86 | cellular protein complex localization (GO:0034629) | 2.78871362 |
| 87 | stress fiber assembly (GO:0043149) | 2.78260851 |
| 88 | negative regulation of fatty acid transport (GO:2000192) | 2.77898768 |
| 89 | negative regulation of cell killing (GO:0031342) | 2.77565625 |
| 90 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.77565625 |
| 91 | embryonic process involved in female pregnancy (GO:0060136) | 2.76477889 |
| 92 | activation of MAPKKK activity (GO:0000185) | 2.75958599 |
| 93 | tachykinin receptor signaling pathway (GO:0007217) | 2.75176844 |
| 94 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.74808216 |
| 95 | cell-substrate junction assembly (GO:0007044) | 2.74608158 |
| 96 | activation of Rac GTPase activity (GO:0032863) | 2.74024441 |
| 97 | vitamin A metabolic process (GO:0006776) | 2.73796995 |
| 98 | modulation by symbiont of host cellular process (GO:0044068) | 2.73784057 |
| 99 | semaphorin-plexin signaling pathway (GO:0071526) | 2.73017891 |
| 100 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.72241450 |
| 101 | cellular modified amino acid catabolic process (GO:0042219) | 2.70429123 |
| 102 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.69339764 |
| 103 | protein retention in ER lumen (GO:0006621) | 2.68638656 |
| 104 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.67212466 |
| 105 | epithelial cell-cell adhesion (GO:0090136) | 2.67005497 |
| 106 | primitive streak formation (GO:0090009) | 2.66191517 |
| 107 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.65436650 |
| 108 | negative regulation of bone resorption (GO:0045779) | 2.65410216 |
| 109 | mitotic sister chromatid segregation (GO:0000070) | 2.62873242 |
| 110 | viral transcription (GO:0019083) | 2.61606462 |
| 111 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.60111839 |
| 112 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.60111839 |
| 113 | pentose-phosphate shunt (GO:0006098) | 2.59535518 |
| 114 | cellular senescence (GO:0090398) | 2.58344568 |
| 115 | regulation of early endosome to late endosome transport (GO:2000641) | 2.57994137 |
| 116 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 2.57924163 |
| 117 | thymic T cell selection (GO:0045061) | 2.57601695 |
| 118 | modulation by virus of host process (GO:0019054) | 2.55384636 |
| 119 | regulation of protein deacetylation (GO:0090311) | 2.54536357 |
| 120 | response to muramyl dipeptide (GO:0032495) | 2.54431342 |
| 121 | epoxygenase P450 pathway (GO:0019373) | 2.54147577 |
| 122 | histone lysine demethylation (GO:0070076) | 2.54005005 |
| 123 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.53153993 |
| 124 | regulation of histone deacetylation (GO:0031063) | 2.52875178 |
| 125 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.50633221 |
| 126 | protein localization to endosome (GO:0036010) | 2.50030122 |
| 127 | regulation of translational fidelity (GO:0006450) | 2.48775463 |
| 128 | protein localization to chromosome, centromeric region (GO:0071459) | 2.47078619 |
| 129 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.46192429 |
| 130 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.45976317 |
| 131 | pinocytosis (GO:0006907) | 2.45887589 |
| 132 | cell-cell junction maintenance (GO:0045217) | 2.45241379 |
| 133 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.44894921 |
| 134 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.43058980 |
| 135 | sister chromatid segregation (GO:0000819) | 2.42389529 |
| 136 | regulation of Rap GTPase activity (GO:0032317) | 2.40694416 |
| 137 | histone demethylation (GO:0016577) | 2.40284456 |
| 138 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.39701879 |
| 139 | nucleosome disassembly (GO:0006337) | 2.39426805 |
| 140 | protein-DNA complex disassembly (GO:0032986) | 2.39426805 |
| 141 | embryonic eye morphogenesis (GO:0048048) | 2.38816254 |
| 142 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.38781635 |
| 143 | intestinal epithelial cell development (GO:0060576) | 2.38752340 |
| 144 | DNA unwinding involved in DNA replication (GO:0006268) | 2.38344555 |
| 145 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.37694555 |
| 146 | positive thymic T cell selection (GO:0045059) | 2.37485893 |
| 147 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.36857627 |
| 148 | ear development (GO:0043583) | 2.36163734 |
| 149 | cellular response to osmotic stress (GO:0071470) | 2.36119058 |
| 150 | response to laminar fluid shear stress (GO:0034616) | 2.35800110 |
| 151 | regulation of ARF GTPase activity (GO:0032312) | 2.34995195 |
| 152 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.34889761 |
| 153 | nuclear pore organization (GO:0006999) | 2.34701372 |
| 154 | atrioventricular valve morphogenesis (GO:0003181) | 2.33782062 |
| 155 | proline biosynthetic process (GO:0006561) | 2.33136886 |
| 156 | cellular response to virus (GO:0098586) | 2.33100191 |
| 157 | regulation of cholesterol homeostasis (GO:2000188) | 2.32714701 |
| 158 | histone H3-K4 methylation (GO:0051568) | 2.32593257 |
| 159 | negative regulation of glial cell proliferation (GO:0060253) | 2.32585637 |
| 160 | regulation of macrophage cytokine production (GO:0010935) | 2.32060010 |
| 161 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.31828031 |
| 162 | regulation of extracellular matrix disassembly (GO:0010715) | 2.31487940 |
| 163 | negative regulation of phagocytosis (GO:0050765) | 2.31214556 |
| 164 | embryonic placenta development (GO:0001892) | 2.30494636 |
| 165 | NIK/NF-kappaB signaling (GO:0038061) | 2.28392474 |
| 166 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.28345747 |
| 167 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.28244926 |
| 168 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.28244926 |
| 169 | translational termination (GO:0006415) | 2.28103395 |
| 170 | negative regulation of histone methylation (GO:0031061) | 2.27657361 |
| 171 | response to peptidoglycan (GO:0032494) | 2.27320724 |
| 172 | receptor recycling (GO:0001881) | 2.27142425 |
| 173 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.26115420 |
| 174 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.26115420 |
| 175 | modulation by symbiont of host immune response (GO:0052553) | 2.26115420 |
| 176 | positive regulation by symbiont of host defense response (GO:0052509) | 2.26115420 |
| 177 | modulation by symbiont of host defense response (GO:0052031) | 2.26115420 |
| 178 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.26115420 |
| 179 | response to epidermal growth factor (GO:0070849) | 2.26012547 |
| 180 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.24694130 |
| 181 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.24421548 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.22205303 |
| 2 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.58492349 |
| 3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.58492349 |
| 4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.58492349 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.07425269 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.92746992 |
| 7 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.71078517 |
| 8 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.51731646 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.48244445 |
| 10 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.23046759 |
| 11 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.20007426 |
| 12 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.17728217 |
| 13 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.10129804 |
| 14 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.08595854 |
| 15 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.07675479 |
| 16 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.01209169 |
| 17 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.99800282 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.99108115 |
| 19 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.95137354 |
| 20 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.94143426 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.93834793 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.88425893 |
| 23 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.88151432 |
| 24 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.87628931 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.78515586 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.78192915 |
| 27 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.75873545 |
| 28 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.73457654 |
| 29 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.68998676 |
| 30 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.64804338 |
| 31 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.63921443 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62397129 |
| 33 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.62195035 |
| 34 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.61320944 |
| 35 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.60932721 |
| 36 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.59782094 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.59496085 |
| 38 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.59237753 |
| 39 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.53559423 |
| 40 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.53292338 |
| 41 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.52718505 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.51820264 |
| 43 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.51577791 |
| 44 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.51402499 |
| 45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.50948381 |
| 46 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.50658112 |
| 47 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45134002 |
| 48 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.44271755 |
| 49 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.42842026 |
| 50 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.42572263 |
| 51 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.42390750 |
| 52 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.41641007 |
| 53 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.40964072 |
| 54 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.40481403 |
| 55 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.40237320 |
| 56 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.38107410 |
| 57 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.37362030 |
| 58 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.36996490 |
| 59 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35755064 |
| 60 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.35594914 |
| 61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35387242 |
| 62 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.34698071 |
| 63 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.34398766 |
| 64 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.34077666 |
| 65 | UTX_26944678_Chip-Seq_JUKART_Human | 1.33458693 |
| 66 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.32817754 |
| 67 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.32402946 |
| 68 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.32314213 |
| 69 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.30520709 |
| 70 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.29120527 |
| 71 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27394070 |
| 72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.26423369 |
| 73 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.26349805 |
| 74 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.26296845 |
| 75 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.26108835 |
| 76 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.25524803 |
| 77 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.25328394 |
| 78 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25072438 |
| 79 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.24946310 |
| 80 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.24757089 |
| 81 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.24219455 |
| 82 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.23944838 |
| 83 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.23861774 |
| 84 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.23294591 |
| 85 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22758706 |
| 86 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.22702782 |
| 87 | ATF3_27146783_Chip-Seq_COLON_Human | 1.22331667 |
| 88 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.22074325 |
| 89 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.21517888 |
| 90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21162873 |
| 91 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19923068 |
| 92 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19238969 |
| 93 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19006808 |
| 94 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.16675878 |
| 95 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.16258035 |
| 96 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15650837 |
| 97 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.15005936 |
| 98 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14432166 |
| 99 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.13729378 |
| 100 | P68_20966046_ChIP-Seq_HELA_Human | 1.13621272 |
| 101 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13033429 |
| 102 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12473742 |
| 103 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.11898417 |
| 104 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11377085 |
| 105 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10220725 |
| 106 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.09654124 |
| 107 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.08179323 |
| 108 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.07718273 |
| 109 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.04860894 |
| 110 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.03981030 |
| 111 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03897834 |
| 112 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.02524172 |
| 113 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.02208037 |
| 114 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01421020 |
| 115 | MYB_26560356_Chip-Seq_TH1_Human | 1.01123970 |
| 116 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00929244 |
| 117 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00054081 |
| 118 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.99648167 |
| 119 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.99100637 |
| 120 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98957494 |
| 121 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.98405190 |
| 122 | MAF_26560356_Chip-Seq_TH2_Human | 0.97831827 |
| 123 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97747403 |
| 124 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.97693813 |
| 125 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97380842 |
| 126 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96456116 |
| 127 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96438984 |
| 128 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96372738 |
| 129 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95296335 |
| 130 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.95024324 |
| 131 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.94943203 |
| 132 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94218615 |
| 133 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.94105086 |
| 134 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.93594412 |
| 135 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.93459569 |
| 136 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.91892544 |
| 137 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91382078 |
| 138 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.91265070 |
| 139 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90390252 |
| 140 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.89494916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 4.30002574 |
| 2 | MP0004858_abnormal_nervous_system | 4.11095662 |
| 3 | MP0002254_reproductive_system_inflammat | 4.03803428 |
| 4 | MP0008961_abnormal_basal_metabolism | 3.63107546 |
| 5 | MP0004264_abnormal_extraembryonic_tissu | 3.31733989 |
| 6 | MP0010352_gastrointestinal_tract_polyps | 3.14863843 |
| 7 | MP0005451_abnormal_body_composition | 3.06358170 |
| 8 | MP0005058_abnormal_lysosome_morphology | 2.90209713 |
| 9 | MP0003303_peritoneal_inflammation | 2.73348672 |
| 10 | MP0005076_abnormal_cell_differentiation | 2.21536329 |
| 11 | MP0002796_impaired_skin_barrier | 2.19538317 |
| 12 | MP0003122_maternal_imprinting | 2.15679181 |
| 13 | MP0003890_abnormal_embryonic-extraembry | 2.14967181 |
| 14 | MP0005257_abnormal_intraocular_pressure | 2.14709765 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.09449501 |
| 16 | MP0001849_ear_inflammation | 1.98142732 |
| 17 | MP0005394_taste/olfaction_phenotype | 1.96479849 |
| 18 | MP0005499_abnormal_olfactory_system | 1.96479849 |
| 19 | MP0005409_darkened_coat_color | 1.96355897 |
| 20 | MP0003183_abnormal_peptide_metabolism | 1.94017018 |
| 21 | MP0002877_abnormal_melanocyte_morpholog | 1.88525562 |
| 22 | MP0004510_myositis | 1.86579857 |
| 23 | MP0006082_CNS_inflammation | 1.83999806 |
| 24 | MP0003011_delayed_dark_adaptation | 1.77064105 |
| 25 | MP0002332_abnormal_exercise_endurance | 1.75985161 |
| 26 | MP0004381_abnormal_hair_follicle | 1.72317361 |
| 27 | MP0008260_abnormal_autophagy | 1.68450938 |
| 28 | MP0000537_abnormal_urethra_morphology | 1.67627344 |
| 29 | MP0009672_abnormal_birth_weight | 1.65638096 |
| 30 | MP0001348_abnormal_lacrimal_gland | 1.65219624 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.62158489 |
| 32 | MP0002653_abnormal_ependyma_morphology | 1.61881498 |
| 33 | MP0003763_abnormal_thymus_physiology | 1.58273859 |
| 34 | MP0009278_abnormal_bone_marrow | 1.56051770 |
| 35 | MP0004233_abnormal_muscle_weight | 1.49028632 |
| 36 | MP0002088_abnormal_embryonic_growth/wei | 1.46602279 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.45180121 |
| 38 | MP0003566_abnormal_cell_adhesion | 1.44683907 |
| 39 | MP0003984_embryonic_growth_retardation | 1.43783073 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.40056107 |
| 41 | MP0005380_embryogenesis_phenotype | 1.39192601 |
| 42 | MP0001672_abnormal_embryogenesis/_devel | 1.39192601 |
| 43 | MP0005501_abnormal_skin_physiology | 1.36950391 |
| 44 | MP0004185_abnormal_adipocyte_glucose | 1.35284575 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.34724600 |
| 46 | MP0003436_decreased_susceptibility_to | 1.34592282 |
| 47 | MP0002086_abnormal_extraembryonic_tissu | 1.34574172 |
| 48 | MP0002249_abnormal_larynx_morphology | 1.33919082 |
| 49 | MP0003121_genomic_imprinting | 1.31897091 |
| 50 | MP0003091_abnormal_cell_migration | 1.30142116 |
| 51 | MP0003045_fibrosis | 1.29686343 |
| 52 | MP0000685_abnormal_immune_system | 1.28571129 |
| 53 | MP0001790_abnormal_immune_system | 1.26782775 |
| 54 | MP0005387_immune_system_phenotype | 1.26782775 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.26398637 |
| 56 | MP0008770_decreased_survivor_rate | 1.26387000 |
| 57 | MP0005310_abnormal_salivary_gland | 1.24272432 |
| 58 | MP0005623_abnormal_meninges_morphology | 1.20762854 |
| 59 | MP0000678_abnormal_parathyroid_gland | 1.17993699 |
| 60 | MP0003828_pulmonary_edema | 1.16729206 |
| 61 | MP0005666_abnormal_adipose_tissue | 1.16407368 |
| 62 | MP0005023_abnormal_wound_healing | 1.13145444 |
| 63 | MP0010234_abnormal_vibrissa_follicle | 1.12143492 |
| 64 | MP0003123_paternal_imprinting | 1.12063032 |
| 65 | MP0001727_abnormal_embryo_implantation | 1.11590291 |
| 66 | MP0004859_abnormal_synaptic_plasticity | 1.11318608 |
| 67 | MP0003111_abnormal_nucleus_morphology | 1.10181430 |
| 68 | MP0001800_abnormal_humoral_immune | 1.09673124 |
| 69 | MP0004782_abnormal_surfactant_physiolog | 1.09017919 |
| 70 | MP0003693_abnormal_embryo_hatching | 1.08911859 |
| 71 | MP0000350_abnormal_cell_proliferation | 1.08440894 |
| 72 | MP0004947_skin_inflammation | 1.07993315 |
| 73 | MP0002998_abnormal_bone_remodeling | 1.07428828 |
| 74 | MP0002970_abnormal_white_adipose | 1.07203426 |
| 75 | MP0006292_abnormal_olfactory_placode | 1.04165094 |
| 76 | MP0002396_abnormal_hematopoietic_system | 1.03809340 |
| 77 | MP0002089_abnormal_postnatal_growth/wei | 1.02954379 |
| 78 | MP0004957_abnormal_blastocyst_morpholog | 0.99805658 |
| 79 | MP0003075_altered_response_to | 0.99798001 |
| 80 | MP0004043_abnormal_pH_regulation | 0.99653531 |
| 81 | MP0002925_abnormal_cardiovascular_devel | 0.99560840 |
| 82 | MP0004197_abnormal_fetal_growth/weight/ | 0.99265705 |
| 83 | MP0003283_abnormal_digestive_organ | 0.98656377 |
| 84 | MP0003448_altered_tumor_morphology | 0.98624630 |
| 85 | MP0002132_abnormal_respiratory_system | 0.97860733 |
| 86 | MP0002092_abnormal_eye_morphology | 0.97747297 |
| 87 | MP0003941_abnormal_skin_development | 0.97218349 |
| 88 | MP0003315_abnormal_perineum_morphology | 0.95692850 |
| 89 | MP0009931_abnormal_skin_appearance | 0.95395503 |
| 90 | MP0002405_respiratory_system_inflammati | 0.95014758 |
| 91 | MP0002084_abnormal_developmental_patter | 0.94545560 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.93446488 |
| 93 | MP0005375_adipose_tissue_phenotype | 0.92204816 |
| 94 | MP0000733_abnormal_muscle_development | 0.92097452 |
| 95 | MP0002398_abnormal_bone_marrow | 0.91461283 |
| 96 | MP0002722_abnormal_immune_system | 0.90120925 |
| 97 | MP0001216_abnormal_epidermal_layer | 0.90091690 |
| 98 | MP0000428_abnormal_craniofacial_morphol | 0.89402248 |
| 99 | MP0002060_abnormal_skin_morphology | 0.88583226 |
| 100 | MP0005000_abnormal_immune_tolerance | 0.88346939 |
| 101 | MP0000689_abnormal_spleen_morphology | 0.87523619 |
| 102 | MP0006035_abnormal_mitochondrial_morpho | 0.87221683 |
| 103 | MP0003329_amyloid_beta_deposits | 0.85386623 |
| 104 | MP0002085_abnormal_embryonic_tissue | 0.84946414 |
| 105 | MP0008004_abnormal_stomach_pH | 0.84639252 |
| 106 | MP0001835_abnormal_antigen_presentation | 0.84307596 |
| 107 | MP0001730_embryonic_growth_arrest | 0.80359734 |
| 108 | MP0001545_abnormal_hematopoietic_system | 0.80086208 |
| 109 | MP0005397_hematopoietic_system_phenotyp | 0.80086208 |
| 110 | MP0000703_abnormal_thymus_morphology | 0.79744577 |
| 111 | MP0010630_abnormal_cardiac_muscle | 0.79336843 |
| 112 | MP0009053_abnormal_anal_canal | 0.78950545 |
| 113 | MP0000377_abnormal_hair_follicle | 0.78320802 |
| 114 | MP0000858_altered_metastatic_potential | 0.77828829 |
| 115 | MP0003115_abnormal_respiratory_system | 0.77484643 |
| 116 | MP0003119_abnormal_digestive_system | 0.77329014 |
| 117 | MP0000716_abnormal_immune_system | 0.76522145 |
| 118 | MP0004272_abnormal_basement_membrane | 0.76396354 |
| 119 | MP0002452_abnormal_antigen_presenting | 0.76114408 |
| 120 | MP0002269_muscular_atrophy | 0.75743463 |
| 121 | MP0000767_abnormal_smooth_muscle | 0.75601359 |
| 122 | MP0010307_abnormal_tumor_latency | 0.75286135 |
| 123 | MP0008438_abnormal_cutaneous_collagen | 0.75240061 |
| 124 | MP0010030_abnormal_orbit_morphology | 0.74836166 |
| 125 | MP0009115_abnormal_fat_cell | 0.74429099 |
| 126 | MP0001915_intracranial_hemorrhage | 0.74310086 |
| 127 | MP0001697_abnormal_embryo_size | 0.74015155 |
| 128 | MP0002098_abnormal_vibrissa_morphology | 0.72855400 |
| 129 | MP0000490_abnormal_crypts_of | 0.72757794 |
| 130 | MP0000477_abnormal_intestine_morphology | 0.72712064 |
| 131 | MP0005025_abnormal_response_to | 0.72459515 |
| 132 | MP0004087_abnormal_muscle_fiber | 0.72325753 |
| 133 | MP0002429_abnormal_blood_cell | 0.72204319 |
| 134 | MP0004808_abnormal_hematopoietic_stem | 0.71498202 |
| 135 | MP0000313_abnormal_cell_death | 0.70971911 |
| 136 | MP0002420_abnormal_adaptive_immunity | 0.70951371 |
| 137 | MP0001819_abnormal_immune_cell | 0.70921934 |
| 138 | MP0001873_stomach_inflammation | 0.70890561 |
| 139 | MP0000759_abnormal_skeletal_muscle | 0.70854965 |
| 140 | MP0009840_abnormal_foam_cell | 0.70763856 |
| 141 | MP0002080_prenatal_lethality | 0.70442299 |
| 142 | MP0000627_abnormal_mammary_gland | 0.70347073 |
| 143 | MP0001881_abnormal_mammary_gland | 0.69900237 |
| 144 | MP0002419_abnormal_innate_immunity | 0.69022271 |
| 145 | MP0010155_abnormal_intestine_physiology | 0.68928783 |
| 146 | MP0002127_abnormal_cardiovascular_syste | 0.68658228 |
| 147 | MP0003077_abnormal_cell_cycle | 0.68411266 |
| 148 | MP0005621_abnormal_cell_physiology | 0.68220867 |
| 149 | MP0002723_abnormal_immune_serum | 0.66378918 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the lower motor neuron (HP:0002366) | 4.86135261 |
| 2 | Bilateral microphthalmos (HP:0007633) | 4.54410293 |
| 3 | Hypochromic microcytic anemia (HP:0004840) | 3.89641051 |
| 4 | Multiple enchondromatosis (HP:0005701) | 3.87640378 |
| 5 | Hepatoblastoma (HP:0002884) | 3.84532411 |
| 6 | Ependymoma (HP:0002888) | 3.38141098 |
| 7 | Hand muscle atrophy (HP:0009130) | 3.34981368 |
| 8 | Distal upper limb amyotrophy (HP:0007149) | 3.25135065 |
| 9 | Upper limb amyotrophy (HP:0009129) | 3.25135065 |
| 10 | Nasal polyposis (HP:0100582) | 3.16446893 |
| 11 | Rib fusion (HP:0000902) | 2.99146315 |
| 12 | Amyotrophic lateral sclerosis (HP:0007354) | 2.92210862 |
| 13 | Obstructive sleep apnea (HP:0002870) | 2.84426683 |
| 14 | Abnormality of the astrocytes (HP:0100707) | 2.82336070 |
| 15 | Astrocytoma (HP:0009592) | 2.82336070 |
| 16 | Abnormality of the nasal mucosa (HP:0000433) | 2.79590328 |
| 17 | Difficulty running (HP:0009046) | 2.76603972 |
| 18 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.76539320 |
| 19 | Thoracic kyphosis (HP:0002942) | 2.71396946 |
| 20 | Neoplasm of striated muscle (HP:0009728) | 2.69010722 |
| 21 | Abnormality of the thoracic spine (HP:0100711) | 2.68789637 |
| 22 | Achilles tendon contracture (HP:0001771) | 2.68019372 |
| 23 | Macroorchidism (HP:0000053) | 2.67807629 |
| 24 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.67176495 |
| 25 | Neoplasm of the heart (HP:0100544) | 2.63394384 |
| 26 | Long palpebral fissure (HP:0000637) | 2.61849690 |
| 27 | Testicular atrophy (HP:0000029) | 2.60497368 |
| 28 | Generalized hypotonia (HP:0001290) | 2.58768797 |
| 29 | Broad face (HP:0000283) | 2.57786306 |
| 30 | Increased connective tissue (HP:0009025) | 2.56697548 |
| 31 | Resting tremor (HP:0002322) | 2.52625900 |
| 32 | Thin bony cortex (HP:0002753) | 2.50860155 |
| 33 | Abnormality of the Achilles tendon (HP:0005109) | 2.46844652 |
| 34 | Disproportionate tall stature (HP:0001519) | 2.40810664 |
| 35 | Ulnar bowing (HP:0003031) | 2.37408075 |
| 36 | Insomnia (HP:0100785) | 2.36068585 |
| 37 | Hypochromic anemia (HP:0001931) | 2.36023251 |
| 38 | Abnormality of the fingertips (HP:0001211) | 2.35514596 |
| 39 | Cerebral aneurysm (HP:0004944) | 2.34554318 |
| 40 | Distal lower limb amyotrophy (HP:0008944) | 2.34058425 |
| 41 | Asymmetry of the thorax (HP:0001555) | 2.32992078 |
| 42 | Renal duplication (HP:0000075) | 2.29901665 |
| 43 | Fused cervical vertebrae (HP:0002949) | 2.27196651 |
| 44 | Abnormality of the musculature of the hand (HP:0001421) | 2.20059063 |
| 45 | Dysmetric saccades (HP:0000641) | 2.19156032 |
| 46 | Deep palmar crease (HP:0006191) | 2.18814669 |
| 47 | Skin tags (HP:0010609) | 2.17844294 |
| 48 | Mitral valve prolapse (HP:0001634) | 2.17675447 |
| 49 | Rhabdomyosarcoma (HP:0002859) | 2.16303118 |
| 50 | Eczematoid dermatitis (HP:0000976) | 2.16087071 |
| 51 | Preauricular skin tag (HP:0000384) | 2.13027286 |
| 52 | Germ cell neoplasia (HP:0100728) | 2.12896447 |
| 53 | Peritonitis (HP:0002586) | 2.11614166 |
| 54 | Amblyopia (HP:0000646) | 2.10761495 |
| 55 | Pseudobulbar signs (HP:0002200) | 2.08793962 |
| 56 | Hyperparathyroidism (HP:0000843) | 2.08157124 |
| 57 | Abnormal cartilage morphology (HP:0002763) | 2.07490429 |
| 58 | Micronodular cirrhosis (HP:0001413) | 2.07176914 |
| 59 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.06846758 |
| 60 | Intestinal fistula (HP:0100819) | 2.06120577 |
| 61 | Apathy (HP:0000741) | 2.05396895 |
| 62 | Patellar dislocation (HP:0002999) | 2.01167999 |
| 63 | Colitis (HP:0002583) | 2.00272061 |
| 64 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.00230831 |
| 65 | Lymphangioma (HP:0100764) | 1.98660574 |
| 66 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.98135317 |
| 67 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.98135317 |
| 68 | Abnormality of glycolipid metabolism (HP:0010969) | 1.98135317 |
| 69 | Large earlobe (HP:0009748) | 1.98085512 |
| 70 | Flat acetabular roof (HP:0003180) | 1.97977657 |
| 71 | Short humerus (HP:0005792) | 1.97283106 |
| 72 | Increased variability in muscle fiber diameter (HP:0003557) | 1.97227544 |
| 73 | Fasciculations (HP:0002380) | 1.97181129 |
| 74 | Vertebral compression fractures (HP:0002953) | 1.96085045 |
| 75 | Polygenic inheritance (HP:0010982) | 1.95003570 |
| 76 | Hyperacusis (HP:0010780) | 1.92658955 |
| 77 | Protrusio acetabuli (HP:0003179) | 1.92202770 |
| 78 | Shallow orbits (HP:0000586) | 1.91425291 |
| 79 | Premature rupture of membranes (HP:0001788) | 1.90925366 |
| 80 | Ankyloglossia (HP:0010296) | 1.90431939 |
| 81 | Abnormality of the columella (HP:0009929) | 1.89069644 |
| 82 | Hypercortisolism (HP:0001578) | 1.88325552 |
| 83 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.87637075 |
| 84 | Diminished motivation (HP:0000745) | 1.87401432 |
| 85 | Angiofibromas (HP:0010615) | 1.87317422 |
| 86 | Adenoma sebaceum (HP:0009720) | 1.87317422 |
| 87 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.87080959 |
| 88 | Pointed chin (HP:0000307) | 1.87020747 |
| 89 | Ragged-red muscle fibers (HP:0003200) | 1.86663537 |
| 90 | Heterotopia (HP:0002282) | 1.85043155 |
| 91 | Abnormality of the salivary glands (HP:0010286) | 1.84850659 |
| 92 | Increased CSF protein (HP:0002922) | 1.84222044 |
| 93 | Horizontal nystagmus (HP:0000666) | 1.83790882 |
| 94 | Distal lower limb muscle weakness (HP:0009053) | 1.83574893 |
| 95 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.82389291 |
| 96 | Villous atrophy (HP:0011473) | 1.82389291 |
| 97 | Spinal cord lesions (HP:0100561) | 1.82178204 |
| 98 | Syringomyelia (HP:0003396) | 1.82178204 |
| 99 | Annular pancreas (HP:0001734) | 1.81742230 |
| 100 | Chest pain (HP:0100749) | 1.81721501 |
| 101 | Hypopigmentation of the fundus (HP:0007894) | 1.80638560 |
| 102 | Overriding aorta (HP:0002623) | 1.80608520 |
| 103 | EMG: neuropathic changes (HP:0003445) | 1.80068326 |
| 104 | Rectal fistula (HP:0100590) | 1.79989902 |
| 105 | Rectovaginal fistula (HP:0000143) | 1.79989902 |
| 106 | Skin nodule (HP:0200036) | 1.79848783 |
| 107 | Turricephaly (HP:0000262) | 1.79825107 |
| 108 | Trismus (HP:0000211) | 1.79662008 |
| 109 | Spinal rigidity (HP:0003306) | 1.79576664 |
| 110 | Vertebral arch anomaly (HP:0008438) | 1.79392037 |
| 111 | Increased IgE level (HP:0003212) | 1.78080582 |
| 112 | Subacute progressive viral hepatitis (HP:0006572) | 1.77745579 |
| 113 | Vaginal fistula (HP:0004320) | 1.77333459 |
| 114 | Gastrointestinal inflammation (HP:0004386) | 1.76763193 |
| 115 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.75320505 |
| 116 | Elfin facies (HP:0004428) | 1.75089199 |
| 117 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.74917962 |
| 118 | Arnold-Chiari malformation (HP:0002308) | 1.74539034 |
| 119 | Genu recurvatum (HP:0002816) | 1.74037836 |
| 120 | Short 5th finger (HP:0009237) | 1.73639087 |
| 121 | Upper motor neuron abnormality (HP:0002127) | 1.73320423 |
| 122 | Tetraplegia (HP:0002445) | 1.71795027 |
| 123 | Myopathic facies (HP:0002058) | 1.71303665 |
| 124 | Slow saccadic eye movements (HP:0000514) | 1.71206396 |
| 125 | Malignant neoplasm of the central nervous system (HP:0100836) | 1.70525141 |
| 126 | Progressive muscle weakness (HP:0003323) | 1.70524535 |
| 127 | Lower limb amyotrophy (HP:0007210) | 1.70503956 |
| 128 | Cellulitis (HP:0100658) | 1.70348374 |
| 129 | Neonatal hypoglycemia (HP:0001998) | 1.69999512 |
| 130 | Aneurysm (HP:0002617) | 1.69465372 |
| 131 | Broad palm (HP:0001169) | 1.69425364 |
| 132 | Renal cell carcinoma (HP:0005584) | 1.69372558 |
| 133 | Bowel incontinence (HP:0002607) | 1.69324207 |
| 134 | Periauricular skin pits (HP:0100277) | 1.68658019 |
| 135 | Preauricular pit (HP:0004467) | 1.68658019 |
| 136 | Metaphyseal cupping (HP:0003021) | 1.68133494 |
| 137 | Spastic tetraparesis (HP:0001285) | 1.68048795 |
| 138 | Mitral regurgitation (HP:0001653) | 1.67967770 |
| 139 | Leiomyosarcoma (HP:0100243) | 1.67783394 |
| 140 | Uterine leiomyosarcoma (HP:0002891) | 1.67783394 |
| 141 | Reticulocytosis (HP:0001923) | 1.67525381 |
| 142 | Hemorrhage of the eye (HP:0011885) | 1.66789040 |
| 143 | Long eyelashes (HP:0000527) | 1.66324484 |
| 144 | Open mouth (HP:0000194) | 1.65881242 |
| 145 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.64291635 |
| 146 | Vertebral fusion (HP:0002948) | 1.64196610 |
| 147 | Radial bowing (HP:0002986) | 1.63476736 |
| 148 | Advanced eruption of teeth (HP:0006288) | 1.63194078 |
| 149 | Spinal muscular atrophy (HP:0007269) | 1.62714161 |
| 150 | Rapidly progressive (HP:0003678) | 1.62068028 |
| 151 | Neuronal loss in central nervous system (HP:0002529) | 1.61519659 |
| 152 | Cerebral inclusion bodies (HP:0100314) | 1.61444103 |
| 153 | Glioma (HP:0009733) | 1.61393468 |
| 154 | Dilatation of the ascending aorta (HP:0005111) | 1.60933645 |
| 155 | Abnormality of oral frenula (HP:0000190) | 1.60753725 |
| 156 | Fibroma (HP:0010614) | 1.60512471 |
| 157 | Precocious puberty (HP:0000826) | 1.60215232 |
| 158 | Interstitial pulmonary disease (HP:0006530) | 1.60147902 |
| 159 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.60123355 |
| 160 | Septate vagina (HP:0001153) | 1.60038152 |
| 161 | Fragile skin (HP:0001030) | 1.59592467 |
| 162 | Selective tooth agenesis (HP:0001592) | 1.59008803 |
| 163 | Abnormal large intestine physiology (HP:0012700) | 1.58707018 |
| 164 | Persistence of primary teeth (HP:0006335) | 1.58031104 |
| 165 | Short nail (HP:0001799) | 1.57995226 |
| 166 | Hypercalcemia (HP:0003072) | 1.57861546 |
| 167 | Back pain (HP:0003418) | 1.56316581 |
| 168 | Multiple lipomas (HP:0001012) | 1.55887583 |
| 169 | Self-mutilation (HP:0000742) | 1.54896258 |
| 170 | Easy fatigability (HP:0003388) | 1.53841282 |
| 171 | Deviation of the thumb (HP:0009603) | 1.53538844 |
| 172 | Broad distal phalanx of finger (HP:0009836) | 1.52602353 |
| 173 | Increased cerebral lipofuscin (HP:0011813) | 1.51457054 |
| 174 | Bone pain (HP:0002653) | 1.51269649 |
| 175 | Dislocated radial head (HP:0003083) | 1.49327715 |
| 176 | Decreased motor nerve conduction velocity (HP:0003431) | 1.48852889 |
| 177 | Truncus arteriosus (HP:0001660) | 1.48825038 |
| 178 | Abnormality of macrophages (HP:0004311) | 1.47533552 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 6.45212212 |
| 2 | ERN1 | 4.45501704 |
| 3 | PRPF4B | 3.92992069 |
| 4 | SMG1 | 3.79878767 |
| 5 | GRK6 | 3.65632992 |
| 6 | GRK5 | 3.20784924 |
| 7 | TRIB3 | 3.16010196 |
| 8 | MAP3K10 | 2.60615865 |
| 9 | TYRO3 | 2.47056440 |
| 10 | IRAK3 | 2.08685910 |
| 11 | CSF1R | 2.05440510 |
| 12 | STK10 | 1.98934629 |
| 13 | PKN2 | 1.98339989 |
| 14 | MAP3K9 | 1.97678686 |
| 15 | NME2 | 1.95280596 |
| 16 | EEF2K | 1.84119103 |
| 17 | TGFBR2 | 1.78057382 |
| 18 | MATK | 1.66854666 |
| 19 | EPHA2 | 1.62116566 |
| 20 | NTRK1 | 1.48568184 |
| 21 | MOS | 1.46065018 |
| 22 | ALK | 1.44144121 |
| 23 | RIPK1 | 1.43878408 |
| 24 | TAOK2 | 1.43391813 |
| 25 | FGFR3 | 1.40115114 |
| 26 | WNK1 | 1.29315406 |
| 27 | TAOK1 | 1.28880484 |
| 28 | MAPK7 | 1.27790732 |
| 29 | ICK | 1.25844161 |
| 30 | BMX | 1.24913679 |
| 31 | PDGFRA | 1.23667719 |
| 32 | MARK2 | 1.23089902 |
| 33 | MAP4K1 | 1.22816469 |
| 34 | SIK2 | 1.22702031 |
| 35 | MAP2K3 | 1.19063997 |
| 36 | HIPK2 | 1.18225797 |
| 37 | KSR2 | 1.16147673 |
| 38 | MAP3K7 | 1.11781280 |
| 39 | GRK1 | 1.08747328 |
| 40 | PRKG2 | 1.08262286 |
| 41 | BRD4 | 1.02588714 |
| 42 | CSK | 1.00313860 |
| 43 | RPS6KA2 | 1.00276346 |
| 44 | PAK4 | 1.00051817 |
| 45 | CAMK4 | 0.97239397 |
| 46 | ADRBK2 | 0.96072311 |
| 47 | MTOR | 0.93905537 |
| 48 | MAP3K11 | 0.93479802 |
| 49 | MAP2K4 | 0.90065479 |
| 50 | PTK6 | 0.89684929 |
| 51 | PTK2 | 0.88723658 |
| 52 | MAP3K3 | 0.86304181 |
| 53 | PRKD3 | 0.86013334 |
| 54 | RPS6KB2 | 0.85811923 |
| 55 | SIK1 | 0.83713822 |
| 56 | LATS2 | 0.83416540 |
| 57 | MAP2K2 | 0.83131928 |
| 58 | MAP3K2 | 0.82745128 |
| 59 | MAP3K8 | 0.82269066 |
| 60 | TTK | 0.81572060 |
| 61 | PASK | 0.81290830 |
| 62 | RPS6KL1 | 0.80837495 |
| 63 | RPS6KC1 | 0.80837495 |
| 64 | ARAF | 0.80012821 |
| 65 | LRRK2 | 0.78440492 |
| 66 | IRAK2 | 0.76686387 |
| 67 | PDPK1 | 0.74635470 |
| 68 | RET | 0.73517658 |
| 69 | SCYL2 | 0.72551109 |
| 70 | BRAF | 0.72276687 |
| 71 | MAP3K14 | 0.70840132 |
| 72 | TTN | 0.70593790 |
| 73 | RIPK4 | 0.69260208 |
| 74 | PAK6 | 0.66121313 |
| 75 | MARK3 | 0.63858316 |
| 76 | JAK3 | 0.63812908 |
| 77 | JAK2 | 0.62674506 |
| 78 | PRKD2 | 0.62366221 |
| 79 | FGFR4 | 0.62229017 |
| 80 | DYRK3 | 0.59644920 |
| 81 | PRKCH | 0.59332499 |
| 82 | IRAK4 | 0.57563754 |
| 83 | MAP3K6 | 0.57102384 |
| 84 | RPS6KA6 | 0.55945781 |
| 85 | CDK7 | 0.55130149 |
| 86 | EPHB1 | 0.55052793 |
| 87 | GRK7 | 0.55007773 |
| 88 | HCK | 0.54887114 |
| 89 | RPS6KA1 | 0.54771124 |
| 90 | DAPK2 | 0.54395361 |
| 91 | TYK2 | 0.54156020 |
| 92 | JAK1 | 0.53997291 |
| 93 | ITK | 0.53536144 |
| 94 | DDR2 | 0.52985968 |
| 95 | MAPK12 | 0.52974454 |
| 96 | MST1R | 0.52722944 |
| 97 | SGK3 | 0.51425274 |
| 98 | SIK3 | 0.51287559 |
| 99 | PDGFRB | 0.50496351 |
| 100 | CDK4 | 0.50272474 |
| 101 | CHUK | 0.48731418 |
| 102 | BTK | 0.47823375 |
| 103 | TBK1 | 0.47695039 |
| 104 | PDK1 | 0.47242766 |
| 105 | MAP3K13 | 0.46987238 |
| 106 | ZAP70 | 0.46699295 |
| 107 | STK38 | 0.45748634 |
| 108 | LATS1 | 0.44364017 |
| 109 | CAMKK1 | 0.43448177 |
| 110 | AKT2 | 0.41417949 |
| 111 | NEK2 | 0.41208993 |
| 112 | CAMK1G | 0.40305472 |
| 113 | MAPK11 | 0.39707887 |
| 114 | STK3 | 0.39337430 |
| 115 | EGFR | 0.38173552 |
| 116 | MELK | 0.38065896 |
| 117 | IKBKB | 0.37983403 |
| 118 | STK11 | 0.37751306 |
| 119 | CLK1 | 0.37069756 |
| 120 | FGR | 0.35836195 |
| 121 | ADRBK1 | 0.35448177 |
| 122 | CDK9 | 0.35346266 |
| 123 | MAP3K1 | 0.34934920 |
| 124 | MAPKAPK2 | 0.32548456 |
| 125 | PAK2 | 0.32218191 |
| 126 | CHEK1 | 0.31490153 |
| 127 | INSR | 0.31027880 |
| 128 | DMPK | 0.30655830 |
| 129 | SYK | 0.30557221 |
| 130 | CAMK1D | 0.28121534 |
| 131 | GSK3A | 0.28036312 |
| 132 | MAPK10 | 0.27625114 |
| 133 | CDK6 | 0.27623913 |
| 134 | DYRK1B | 0.26870894 |
| 135 | NTRK3 | 0.26088222 |
| 136 | BLK | 0.25957654 |
| 137 | PAK3 | 0.25946393 |
| 138 | CDC42BPA | 0.24854045 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.89447550 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.49259683 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.33065384 |
| 4 | mTOR signaling pathway_Homo sapiens_hsa04150 | 2.25903922 |
| 5 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.88371472 |
| 6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.69838882 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.67577764 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.66551103 |
| 9 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.65032629 |
| 10 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.51850473 |
| 11 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.47938661 |
| 12 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.47309926 |
| 13 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.46431933 |
| 14 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.43526344 |
| 15 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.41095979 |
| 16 | Prostate cancer_Homo sapiens_hsa05215 | 1.36943235 |
| 17 | Prion diseases_Homo sapiens_hsa05020 | 1.36033949 |
| 18 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.35574047 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.32567572 |
| 20 | Thyroid cancer_Homo sapiens_hsa05216 | 1.27585357 |
| 21 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.26604627 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.26428177 |
| 23 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.26376245 |
| 24 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.25358000 |
| 25 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.24521847 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.18863630 |
| 27 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.18128503 |
| 28 | Glioma_Homo sapiens_hsa05214 | 1.17572694 |
| 29 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.11759856 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11598899 |
| 31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.10237013 |
| 32 | Galactose metabolism_Homo sapiens_hsa00052 | 1.09095337 |
| 33 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.08385542 |
| 34 | Insulin resistance_Homo sapiens_hsa04931 | 1.06973640 |
| 35 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.06946306 |
| 36 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.06498121 |
| 37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.06493465 |
| 38 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.05976827 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.05878076 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.01494668 |
| 41 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.00897541 |
| 42 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.00141626 |
| 43 | Bladder cancer_Homo sapiens_hsa05219 | 0.99834422 |
| 44 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.99247602 |
| 45 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.98383203 |
| 46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.97401869 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.96958381 |
| 48 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.96556232 |
| 49 | Endometrial cancer_Homo sapiens_hsa05213 | 0.96216563 |
| 50 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.93402464 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 0.93253082 |
| 52 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.92399604 |
| 53 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.92373890 |
| 54 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.92279161 |
| 55 | Colorectal cancer_Homo sapiens_hsa05210 | 0.92256699 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90295271 |
| 57 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.89325992 |
| 58 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.89027110 |
| 59 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.87448531 |
| 60 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.87219879 |
| 61 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.86500845 |
| 62 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84025775 |
| 63 | Long-term potentiation_Homo sapiens_hsa04720 | 0.83980247 |
| 64 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.81906808 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80836803 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.79201180 |
| 67 | Measles_Homo sapiens_hsa05162 | 0.79152471 |
| 68 | Tuberculosis_Homo sapiens_hsa05152 | 0.78997759 |
| 69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78928962 |
| 70 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.78442716 |
| 71 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.78257375 |
| 72 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.78040255 |
| 73 | Focal adhesion_Homo sapiens_hsa04510 | 0.77771284 |
| 74 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.77173077 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.74887430 |
| 76 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.74602295 |
| 77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.74474753 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74336536 |
| 79 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.74246698 |
| 80 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73542156 |
| 81 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.72509708 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71229339 |
| 83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.70657258 |
| 84 | Adherens junction_Homo sapiens_hsa04520 | 0.70275686 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.69478625 |
| 86 | Lysine degradation_Homo sapiens_hsa00310 | 0.68960907 |
| 87 | Pathways in cancer_Homo sapiens_hsa05200 | 0.68816191 |
| 88 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68594757 |
| 89 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.67928214 |
| 90 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.67667900 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67567920 |
| 92 | Ribosome_Homo sapiens_hsa03010 | 0.67006295 |
| 93 | Influenza A_Homo sapiens_hsa05164 | 0.65708490 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65345817 |
| 95 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.64557093 |
| 96 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.63665964 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62931681 |
| 98 | Bile secretion_Homo sapiens_hsa04976 | 0.62742519 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.62403041 |
| 100 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60327172 |
| 101 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59992984 |
| 102 | Melanogenesis_Homo sapiens_hsa04916 | 0.59947505 |
| 103 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.58459298 |
| 104 | Hepatitis B_Homo sapiens_hsa05161 | 0.58097597 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57345122 |
| 106 | Lysosome_Homo sapiens_hsa04142 | 0.56890898 |
| 107 | Melanoma_Homo sapiens_hsa05218 | 0.56718716 |
| 108 | Hepatitis C_Homo sapiens_hsa05160 | 0.55617829 |
| 109 | Shigellosis_Homo sapiens_hsa05131 | 0.55199849 |
| 110 | Malaria_Homo sapiens_hsa05144 | 0.54203748 |
| 111 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.53492396 |
| 112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52931836 |
| 113 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.51597939 |
| 114 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.51319995 |
| 115 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.51269332 |
| 116 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51258918 |
| 117 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51212013 |
| 118 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51132587 |
| 119 | Spliceosome_Homo sapiens_hsa03040 | 0.49994753 |
| 120 | Gap junction_Homo sapiens_hsa04540 | 0.49654631 |
| 121 | Salmonella infection_Homo sapiens_hsa05132 | 0.48324314 |

